Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› Beijing
Clinical trial register · China

Clinical Trials in Beijing, 2026

Every study on the ClinicalTrials.gov registry that lists a site in China and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 19187 matching records held by the registry are in this view. Synced 08 Nov 2026, 03:17 UTC
19187
Studies in scope
all four open statuses
11790
Recruiting now
open to new participants
2028
Lead sponsors
across recruiting studies
Top sites
Beijing 5576 Shanghai 3879 Guangzhou 3345 Hangzhou 1819 Wuhan 1343
Narrow the registerReset
Recruitment status
Phase
Lead sponsor
Peking Union Medical College Hospital271 Beijing Tiantan Hospital219 Cancer Institute and Hospital, Chinese Academy of Medical Sciences205 AstraZeneca191 Peking University People's Hospital166
Site location
Beijing5576 Shanghai3879 Guangzhou3345 Hangzhou1819 Wuhan1343
All 625 locations
Target enrolment
to

Trials with a site in Beijing

5576 of 19187 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Chinese sites
Start
Recruiting
Beijing Chao Yang Hospital
Not applicable
140
Beijing
2025-05-10
Recruiting
Population PK-guided ATG Dosing in Haplo-HSCT
NCT07791576Hematopoietic Stem Cell Transplantation
DrugAnti-Thymocyte Globulin
Chinese PLA General Hospital
Phase 2
63
Beijing
2025-05-10
Recruiting
Luo Yaping
Not applicable
20
Beijing
2025-05-10
Not yet open
Peking University
Phase 1
44
Beijing
2025-05-10
Recruiting
Research on the Application of 68Ga-DOTA-CCK-FS PET/CT in MTC
NCT07138716Medullary Thyroid Carcinoma
Luo Yaping
Not applicable
30
Beijing
2025-05-10
Recruiting
Luo Yaping
Not applicable
46
Beijing
2025-05-10
Recruiting
Peking University Third Hospital
Observational
300
Beijing
2025-05-10
Active, closed
Innovent Biologics (Suzhou) Co. Ltd.
Phase 3
479
Beijing
2025-05-09
Recruiting
ICP-332 in Subjects With Non-segmental Vitiligo
NCT07047612Non Segmental Vitiligo
DrugICP-332
Beijing InnoCare Pharma Tech Co., Ltd.
Phase 2/3
603
Wuhu, Beijing, Chongqing, Fuzhou, Guangzhou, Shijiazhuang, Luoyang, Nanyang
2025-05-09
Recruiting
Biogen
Phase 3
454
Fuyang, Hefei, Beijing, Fuzhou, Xiamen, Lanzhou, Guangzhou, Shenzhen
2025-05-08
By invitation
Meihua Ji
Not applicable
30
Beijing
2025-05-08
Recruiting
Peking University People's Hospital
Observational
100
Beijing
2025-05-08
Recruiting
Staidson (Beijing) Biopharmaceuticals Co., Ltd
Phase 1
64
Beijing
2025-05-08
Not yet open
Gan & Lee Pharmaceuticals.
Phase 1
30
Beijing
2025-05-08
Recruiting
Beijing Municipal Administration of Hospitals
Not applicable
74
Beijing
2025-05-07
Recruiting
Investigation and Classification of Treatable Traits in Patients With Chronic Airway Diseases
NCT07472738Asthma (Diagnosis), Chronic Obstructive Pulmonary Disease (COPD), Chronic Airway Diseases
Beijing Chao Yang Hospital
Observational
950
Beijing
2025-05-07
Recruiting
Beijing Shijitan Hospital, Capital Medical University
Not applicable
369
Beijing
2025-05-07
Recruiting
Study on Water Turnover of the Chinese Population Based on Deuterium Dilution Method
NCT07028021Water Turnover, Population Water Requirements, Deuterium Dilution
Shenzhen Institutes of Advanced Technology ,Chinese Academy of Sciences
Observational
300
Beijing
2025-05-06
Recruiting
AstraZeneca
Phase 3
1,220
Beijing, Changchun, Changsha, Chengdu, Chifeng, Chongqing, Deyang, Fuzhou
2025-05-06
Recruiting
Takeda
Phase 2
88
Beijing, Guangzhou, Changchun, Shanghai
2025-05-06
Recruiting
LaNova Medicines Limited
Phase 1/2
87
Beijing
2025-05-06
Recruiting
Peking Union Medical College Hospital
Observational
90
Beijing
2025-05-04
Recruiting
Guangzhou 8th People's Hospital
Not applicable
210
Guangzhou, Shenzhen, Shijiazhuang, Changsha, Wenzhou, Beijing
2025-05-03
Recruiting
Transcranial Electrical Stimulation for Treating Chronic Pain in Inflammatory Demyelinating Diseases
NCT06942611Idiopathic Inflammatory Demyelinating Disorders of the Central Nervous System
Xuanwu Hospital, Beijing
Not applicable
80
Beijing
2025-05-03
Recruiting
Peking University First Hospital
Phase 2/3
24
Beijing
2025-05-03
Recruiting
BioNTech SE
Phase 1/2
594
Hefei, Beijing, Fuzhou, Nanning, Weihui, Zhengzhou, Jingzhou, Xiangyang
2025-05-02
Not yet open
Peking Union Medical College Hospital
Not applicable
104
Beijing
2025-05-01
Not yet open
Beijing Tiantan Hospital
Observational
242
Beijing
2025-05-01
Not yet open
Tang Ziren
Not applicable
400
Beijing
2025-05-01
Recruiting
CHina Adrenal Venous saMPling InvestigatiON
NCT07252284Hyperaldosteronism, Adrenal Venous Sampling, Adrenalectomy
Chinese Academy of Medical Sciences, Fuwai Hospital
Observational
5,000
Hefei, Beijing, Chongqing, Fuzhou, Xiamen, Lanzhou, Foshan, Guangzhou
2025-05-01
Recruiting
Peking University People's Hospital
Phase 2
56
Beijing
2025-05-01
Active, closed
Liping Dou
Phase 1/2
58
Beijing
2025-05-01
Recruiting
Prediction of LVAR and MACE in STEMI Though Plasma Multiomics Analysis
NCT06885619Left Ventricular Remodeling, Plasma Multi-Omics, Acute ST-segment Elevation Myocardial Infarction, Immunomics
Beijing Anzhen Hospital
Observational
1,000
Beijing
2025-05-01
Not yet open
Relationship Between FGF19 Overexpression and Disease Prognosis
NCT06938451Hepatocellular Carcinoma (HCC)
Beijing Tsinghua Chang Gung Hospital
Observational
100
Beijing
2025-05-01
By invitation
Validation on Clinical Adaptability of the Foundation Model Specific to Neuroimaging Diagnosis
NCT07471984Central Nervous System Disease, MRI, CT, AI (Artificial Intelligence)
Yaou Liu
Observational
50,000
Beijing
2025-05-01
By invitation
Peking University
Phase 2
100
Beijing
2025-05-01
Recruiting
Peking University Cancer Hospital & Institute
Observational
51
Beijing
2025-05-01
Recruiting
Peking University Third Hospital
Observational
4,526
Beijing
2025-05-01
Recruiting
Application of the Sentire C1000 for Ureteral Stricture Repair
NCT06983067Ureteral Stricture, Hydronephrosis
Xuesong Li
Observational
50
Beijing
2025-05-01
By invitation
An Explainable Neuroradiologist Artificial Intelligence Assistance System for Brain CT and MRI
NCT07167043Central Nervous System Disease, MRI, CT, AI (Artificial Intelligence)
Yaou Liu
Observational
30,000
Beijing
2025-05-01
Recruiting
AstraZeneca
Phase 1
72
Beijing, Shanghai, Wuhan, Zhengzhou
2025-05-01
Not yet open
PET-CT to Assess Brain Damage in Cardiac Arrest Patients
NCT06660238Cardiac Arrest, Brain Injuries
Capital Medical University
Observational
30
Beijing
2025-05-01
Not yet open
Peking University Cancer Hospital & Institute
Observational
50
Beijing
2025-05-01
Recruiting
Using 4D Urinary Proteomics to Predict and Evaluate Treatment Response in Colorectal Cancer
NCT06904677Colorectal Cancer (CRC), Neoadjuvant Therapy, Proteomics
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Observational
400
Beijing
2025-05-01
Not yet open
Beijing 302 Hospital
Observational
2,000
Ankang, Anyang, Beihai, Beijing, Binzhou, Changzhi, Changzhou, Chengdu
2025-05-01
Not yet open
Chinese PLA General Hospital
Phase 1/2
30
Beijing
2025-05-01
Recruiting
Beijing Tiantan Hospital
Observational
121
Beijing
2025-05-01
Recruiting
Peking Union Medical College Hospital
Phase 2
70
Beijing
2025-05-01
Not yet open
Xuanwu Hospital, Beijing
Not applicable
30
Beijing
2025-05
Not yet open
Keymed Biosciences Co.Ltd
Phase 3
240
Beijing
2025-05
Recruiting
Preoperative Sleep Intervention on Postoperative Delirium in Infants and Toddlers Undergoing Congenital Heart Surgery
NCT06861998Delirium - Postoperative, Sleep Problems, Congenital Heart Disease (CHD)
Yan Fuxia
Not applicable
452
Beijing
2025-04-30
Recruiting
Hoffmann-La Roche
Observational
800
Zhanjiang, Guangzhou, Kaifeng, Zhengzhou, Ürümqi, Beijing, Changsha, Changzhou
2025-04-30
Recruiting
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Phase 3
199
Hefei, Wuhu, Beijing, Chongqing, Lanzhou, Guangzhou, Shenzhen, Zhanjiang
2025-04-30
Recruiting
Peking University Cancer Hospital & Institute
Phase 2
283
Beijing
2025-04-30
Recruiting
Akeso
Phase 1/2
135
Beijing
2025-04-30
Recruiting
Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd.
Phase 2
216
Beijing
2025-04-30
Active, closed
Eli Lilly and Company
Phase 3
487
Beijing, Changchun, Changde, Chengdu, Chongqing, Jinan, Lishui, Luoyang Shi
2025-04-30
Active, closed
Eli Lilly and Company
Phase 3
974
Beijing, Changchun, Changde, Chengdu, Chongqing, Jinan, Lishui, Luoyang Shi
2025-04-30
Active, closed
Elpiscience (Suzhou) Biopharma, Ltd.
Phase 2
30
Beijing, Zhengzhou, Nanchang, Changchun, Jinan, Luoyang, Taiyuan, Taizhou
2025-04-30
Active, closed
Novartis Pharmaceuticals
Phase 3
246
Yinchuan, Jining, Xian, Beijing, Shanghai
2025-04-30
Active, closed
Eli Lilly and Company
Phase 3
487
Beijing, Changchun, Changde, Chengdu, Chongqing, Jinan, Lishui, Luoyang Shi
2025-04-30
Recruiting
JHM BioPharma (Tonghua) Co. , Ltd.
Phase 3
669
Beijing, Chongqing, Guangzhou, Shijiazhuang, Changsha, Xuzhou, Shanghai, Xianyang
2025-04-30
Active, closed
Study for AZD4360 in Participants With Advanced Solid Tumours
NCT06921928Gastric Cancer, Gastroesophageal Junction Cancer, Biliary Tract Cancer, Pancreatic Ductal Adenocarcinoma
AstraZeneca
Phase 1/2
31
Beijing, Chengdu, Shanghai, Wuhan
2025-04-29
Recruiting
Sequential CD146 and GPC3 CAR-T Cell Therapy in Advanced Ovarian Cancer
NCT07067255Ovarian Cancer, Ovarian Carcinoma, Ovarian Sarcoma, Ovarian Cancer Stage IV
Essen Biotech
Phase 1/2
80
Beijing
2025-04-29
Recruiting
Suzhou Suncadia Biopharmaceuticals Co., Ltd.
Phase 3
380
Beijing
2025-04-29
Recruiting
Sequential CAR-T Cells Targeting BCMA/GPRC5D in Patients With Relapsed/ Refractory Multiple Myeloma
NCT07032129Multiple Myeloma, Multiple Myeloma in Relapse, Multiple Myeloma Progression, Multiple Myeloma, Refractory
Essen Biotech
Phase 1/2
60
Beijing
2025-04-29
Recruiting
Beletalent (Zhuhai) Pharmaceutical Co., Ltd
Phase 3
360
Xuancheng, Beijing, Guangzhou, Shenzhen, Zhuhai, Guiyang, Shijiazhuang, Kaifeng
2025-04-29
Recruiting
Mesothelin and Claudin 18.2 Dual-Target CAR-T Therapy in Advanced Pancreatic Cancer
NCT07066995Pancreatic Cancer, Pancreatic Carcinoma, Pancreatic Cancer Non-resectable, Pancreatic Cancer Stage IV
Essen Biotech
Phase 1/2
60
Beijing
2025-04-29
Recruiting
Xiamen Amoytop Biotech Co., Ltd.
Phase 3
300
Hefei, Beijing, Chongqing, Xiamen, Lanzhou, Guangzhou, Zhengzhou, Wuhan
2025-04-28
Recruiting
Peking Union Medical College Hospital
Observational
800
Beijing
2025-04-28
Recruiting
Clinical Outcomes of Drug-Coated Balloons in the Treatment of Patients With Coronary De Novo Chronic Total Occlusion Lesions
NCT07463664Chronic Total Occlusions of Coronary Arteries, Chronic Total Occlusion (CTO), Coronary Artery Disease (CAD)
The First Affiliated Hospital of Zhengzhou University
Not applicable
200
Beijing, Anyang, Jiaozuo, Jiyuan, Kaifeng, Luoyang, Nanyang, Pingdingshan
2025-04-28
Recruiting
Preoperative Sleep Intervention on Postoperative Delirium in School-aged Children Undergoing Congenital Heart Surgery
NCT06879431Delirium - Postoperative, Sleep Problems, Congenital Heart Disease (CHD)
Yan Fuxia
Not applicable
544
Beijing
2025-04-28
Recruiting
Shandong Suncadia Medicine Co., Ltd.
Phase 2
300
Beijing, Tianjin
2025-04-28
Recruiting
Peking University
Phase 1
10
Beijing
2025-04-27
Recruiting
Cerebral Large Vessel Occlusion Stroke Multiomics Biosample Cohort
NCT06963489Large Vessel Occlusion, Acute Ischemic Stroke
First Affiliated Hospital of Wannan Medical College
Observational
500
Wuhu, Baotou, Jinan, Henan, Beijing
2025-04-27
Not yet open
Efficacy of Fuzheng Tongfu Jiedu Prescription for Treating Gastrointestinal Dysfunction Associated With Sepsis
NCT06933238Sepsis Abdominal, Gastrointestinal Dysfunction, Traditional Chinese Medicine
Dongzhimen Hospital, Beijing
Phase 1/2
70
Beijing
2025-04-25
Recruiting
Study of ISM3412 in Participants With Locally Advanced/Metastatic Solid Tumors
NCT06414460Locally Advanced/Metastatic Solid Tumors
InSilico Medicine Hong Kong Limited
Phase 1/2
146
Beijing, Guangzhou, Nanjing, Shanghai
2025-04-25
Recruiting
pBFS Guided aiTBS Over Language Network for ASD Child
NCT06950437Autism Spectrum Disorder, Language Delay
Beijing Changping Tianhe Research Institute of Brain Science
Not applicable
150
Beijing
2025-04-25
Recruiting
Beijing Emergency Medical Center
Not applicable
952
Beijing
2025-04-25
Recruiting
Suzhou Suncadia Biopharmaceuticals Co., Ltd.
Phase 1/2
100
Beijing
2025-04-25
Recruiting
Beijing Tiantan Hospital
Phase 3
732
Beijing
2025-04-25
Recruiting
Xijing Hospital
Observational
450
Xi'an, Chengdu, Beijing, Shanghai
2025-04-24
Active, closed
Suzhou Suncadia Biopharmaceuticals Co., Ltd.
Phase 3
282
Beijing, Guangzhou
2025-04-24
Recruiting
Arrowhead Pharmaceuticals
Phase 3
288
Beijing, Guangzhou, Guiyang, Harbin, Luoyang, Nanyang, Zhuzhou, Baotou
2025-04-24
Recruiting
Jiangsu HengRui Medicine Co., Ltd.
Phase 1/2
84
Beijing, Shanghai
2025-04-24
Recruiting
Mirati Therapeutics Inc.
Phase 3
630
Bengbu, Hefei, Beijing, Chongqing, Fuzhou Fujian, Xiamen, Guangzhou, Shantou
2025-04-24
Recruiting
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Phase 1/2
90
Bengbu, Ma’anshan, Beijing, Fuzhou, Quanzhou, Lanzhou, Guangzhou, Liuzhou
2025-04-23
Recruiting
Shanghai Junshi Bioscience Co., Ltd.
Phase 2
60
Beijing, Shanghai
2025-04-23
Recruiting
BCI-Assisted SCS-EXS for Gait Optimization
NCT06939660Spinal Cord Injuries (SCI), Spinal Cord Injury, Chronic, Spinal Cord Injury, Spinal Cord Injury Cervical
Xuanwu Hospital, Beijing
Not applicable
3
Beijing
2025-04-23
Recruiting
A Phase IIa Study to Evaluate NBQ72S
NCT06810804Breast Cancer
Nantong Bencao Quadriga Medical Technology Co. Ltd.
Phase 2
10
Beijing
2025-04-22
By invitation
China National Center for Cardiovascular Diseases
Observational
2,400
Beijing
2025-04-22
Active, closed
Cascade Pharmaceuticals, Inc
Phase 1
80
Beijing
2025-04-22
By invitation
Beijing Tiantan Hospital
Not applicable
1,204
Beijing
2025-04-21
Recruiting
Peking University People's Hospital
Not applicable
30
Beijing
2025-04-21
Recruiting
Efficacy of Neoadjuvant Immunotherapy in Patients With Lung Cancer
NCT07166003Lung Cancer, Non-Small Cell, Immunotherapy
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Observational
500
Beijing
2025-04-20
Recruiting
Remote Ischemic Conditioning for Non-Proliferative Diabetic Retinopathy
NCT06713720Diabetic Retinopathy, Non-Proliferative Diabetic Retinopathy, Remote Ischemic Conditioning, Diabetes Mellitus, Type 2
Xuxiang Zhang, MD
Not applicable
68
Beijing
2025-04-20
Active, closed
Effects of HIPEC on Postoperative Bowel Motility and Complications
NCT07353177HIPEC, Gastro Intestinal Cancer, Adhesion Prevention, Bowel Functions
Peking University People's Hospital
Observational
193
Beijing
2025-04-20
Recruiting
CD19-BCMA CART Cell Therapy for Refractory SLE-LN, SSc, and pSS-PAH
NCT06947460Refractory Lupus Nephritis, Systemic Sclerosis, Primary Sjogren's Syndrome Combined With Pulmonary Hypertension, Other Autoimmune Diseases (AID)
DrugAZD0120
Beijing GoBroad Hospital
Phase 1/2
45
Beijing
2025-04-18
Active, closed
Critical Closing Pressure and PCO₂ Gap in Fluid Resuscitation for Septic Shock
NCT07043192Septic Shock, Fluid Resuscitation, Tissue Perfusion Pressure, Carbon Dioxide Pressure
Peking Union Medical College
Observational
60
Beijing
2025-04-18
Recruiting
Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd.
Phase 2
50
Beijing
2025-04-18
Recruiting
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Phase 3
144
Hefei, Beijing, Chongqing, Fuzhou, Lanzhou, Guangzhou, Gui'lin, Liuzhou
2025-04-18
Recruiting
Peking University Sixth Hospital
Not applicable
168
Beijing, Yanan
2025-04-17
Recruiting
Beijing Jishuitan Hospital
Not applicable
290
Beijing
2025-04-16
Recruiting
Pulsed Field Ablation Outcomes With Efficacy and Randomization in Atrial Fibrillation (POWER-AF)
NCT07601763Atrial Fibrillation (AF), Atrial Fibrillation Ablation, Atrial Fibrillation Recurrent, Pulsed Field Ablation
China National Center for Cardiovascular Diseases
Not applicable
1,574
Beijing
2025-04-16
Recruiting
Peking University Third Hospital
Phase 2
58
Beijing
2025-04-15
Recruiting
A Molecular Probe Targeting BCMA for the Clinical Diagnosis of Multiple Myeloma
NCT06717113Multiple Myeloma and Malignant Plasma Cell Neoplasms
DrugFluorodeoxyglucose
Peking University First Hospital
Early Phase 1
50
Beijing
2025-04-15
Not yet open
Peking Union Medical College Hospital
Phase 4
50
Beijing
2025-04-15
Recruiting
FAPI Imaging Predicts Adverse Cardiac Events in Chronic Total Occlusion
NCT07020858Chronic Total Occlusion (CTO), Chronic Coronary Syndrome
Lin Zhao
Observational
470
Beijing
2025-04-15
Recruiting
Peking Union Medical College Hospital
Phase 1/2
20
Beijing
2025-04-15
Active, closed
Bisirna Therapeutics Pte. Ltd.
Phase 1
50
Beijing, Hangzhou
2025-04-15
Recruiting
Tsinghua University
Not applicable
40
Beijing
2025-04-15
Not yet open
Yun Dai Chen
Not applicable
300
Beijing
2025-04-15
Recruiting
Chinese PLA General Hospital
Not applicable
30
Beijing
2025-04-15
Recruiting
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Phase 2
50
Beijing
2025-04-12
Recruiting
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Phase 2
40
Beijing
2025-04-12
Recruiting
Evopoint Biosciences Inc.
Phase 1/2
132
Beijing
2025-04-11
Recruiting
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Phase 1/2
72
Beijing, Chongqing, Harbin, Zhengzhou, Wuhan, Nanjing, Nanchang, Shenyang
2025-04-11
Recruiting
Gan & Lee Pharmaceuticals.
Phase 1
32
Beijing
2025-04-11
Recruiting
CSPC Ouyi Pharmaceutical Co., Ltd.
Phase 3
388
Beijing
2025-04-11
Not yet open
China-Japan Friendship Hospital
Observational
1,400
Beijing
2025-04-10
Recruiting
Evopoint Biosciences Inc.
Phase 3
120
Beijing
2025-04-10
Recruiting
Peking University Third Hospital
Not applicable
56
Beijing
2025-04-10
Recruiting
AstraZeneca
Phase 3
830
Baoding, Beijing, Bengbu, Changchun, Changsha, Chengdu, Chongqing, Fuzhou
2025-04-10
Recruiting
Peking University
Not applicable
120
Beijing
2025-04-10
Not yet open
Efficacy of Remote Ischemic Conditioning in Preventing Post-Stroke Depression
NCT06920706Post-stroke Depression, Remote Ischemic Conditioning
Xuanwu Hospital, Beijing
Not applicable
240
Tongren, Baoding, Jilin City, Jincheng, Beijing
2025-04-10
Recruiting
Study on the Efficacy and Safety of HRS-7535 in Patients With Mild Decrease in Ejection Fraction/Preserved Ejection Fraction Heart Failure and Obesity
NCT06820099Adults With Heart Failure, Mild Decrease in Ejection Fraction/Preserved Ejection Fraction, and Obesity
DrugHRS-7535
Shandong Suncadia Medicine Co., Ltd.
Phase 2
225
Beijing
2025-04-10
Recruiting
Safety and Efficacy of Edoxaban and Rivaroxaban to Cerebral Venous Thrombosis in Chinese Patients
NCT06947707Cerebral Venous Thrombosis, Anticoagulants and Thrombotic Disorders, Anticoagulation Treatment, Anticoagulant Therapy
Xuanwu Hospital, Beijing
Observational
1,486
Beijing
2025-04-10
Recruiting
Epygenix
Phase 3
260
Changsha, Shanghai, Beijing, Changchun, Chengdu, Chongqing, Guangzhou, Guiyang
2025-04-09
Active, closed
Arrowhead Pharmaceuticals
Phase 3
710
Bengbu, Beijing, Guangzhou, Liuzhou, Xingtai, Luoyang, Changsha, Wuhan
2025-04-09
By invitation
Beijing VDJBio Co., LTD.
Phase 3
615
Beijing
2025-04-09
Recruiting
Institute of Hematology & Blood Diseases Hospital, China
Not applicable
20
Beijing, Tianjin
2025-04-09
Recruiting
Hoffmann-La Roche
Phase 3
450
Xiangyang, Beijing, Changsha, Chengdu, Guangzhou, Hangzhou, Harbin, Jiangmen
2025-04-09
By invitation
Beijing Tide Pharmaceutical Co., Ltd
Phase 2
184
Beijing
2025-04-09
Recruiting
Beijing Anzhen Hospital
Not applicable
146
Hefei, Beijing, Xiamen, Guangzhou, Shijiazhuang, Harbin, Zhengzhou, Wuhan
2025-04-08
Recruiting
Peking University Cancer Hospital & Institute
Phase 1/2
42
Neimeng, Baoding, Baotou, Beijing, Dalian, Tianjin
2025-04-08
Recruiting
Peking University
Observational
110
Beijing
2025-04-08
Recruiting
Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd.
Phase 1/2
194
Hefei, Beijing, Fuzhou, Lanzhou, Wuwei, Shenzhen, Nanning, Tangshan
2025-04-08
Recruiting
A Study of Treatment-Related Toxicities and Quality of Life After Local Therapy in Chinese Breast Cancer Patients
NCT07010939Breast Neoplasms, Quality of Life (QOL), Toxicities, Breast Diseases
FangYi
Observational
3,000
Beijing, Shenzhen, Taiyuan
2025-04-07
Not yet open
A Mass Balance Study of [14C]ABSK011
NCT06896760Healthy Subjects
Abbisko Therapeutics Co, Ltd
Phase 1
6
Beijing
2025-04-07
Recruiting
Sirius Therapeutics Co., Ltd.
Phase 1/2
84
Beijing
2025-04-07
Recruiting
BC008-1A Injection for Recurrent CNS WHO G4 Glioma
NCT06773481Glioma, Glioma Tumor Recurrence, Glioma, Recurrent High Grade, Glioblastomas (GBM)
DrugBC008-1A
Sichuan Luzhou Buchang Biopharmaceutical Co., Ltd.
Phase 1
40
Beijing
2025-04-07
Recruiting
Peking University Cancer Hospital & Institute
Not applicable
286
Beijing
2025-04-06
Active, closed
Peking University People's Hospital
Not applicable
86
Beijing
2025-04-05
Recruiting
Gilead Sciences
Phase 3
695
Beijing, Changchun, Chengdu, Chongqing, Fuzhou, Guangzhou, Hangzhou, Harbin
2025-04-04
Active, closed
China-Japan Friendship Hospital
Observational
20
Beijing
2025-04-04
Not yet open
7.0T Magnetic Resonance Imaging Study for Hepatic Encephalopathy
NCT06923254Hepatic Encephalopathy (HE), MRI, fMRI Research
Chinese PLA General Hospital
Observational
200
Beijing
2025-04-03
Recruiting
Heart Health Research Center
Not applicable
1,301
Beijing
2025-04-03
Active, closed
A Phase 1b Study of GKL-006 Injection in Patients With Unresectable Hepatocellular Carcinoma
NCT07713290Hepatocellular Carcinoma (HCC), Unresectable Hepatocellular Cancer
DrugGKL-006
Beijing Gene Key Life Technology Co., Ltd
Phase 1
6
Beijing, Taiyuan
2025-04-03
Not yet open
China International Neuroscience Institution
Phase 4
208
Beijing
2025-04-03
Recruiting
Shanghai JMT-Bio Inc.
Phase 3
350
Beijing
2025-04-03
Recruiting
Beijing Haidian Hospital
Observational
30
Beijing
2025-04-02
Recruiting
Inmunotek S.L.
Phase 3
736
Beijing, Guangzhou, Zhongshan, Xiangya, Changzhou, Qingdao, Shanghai, Tongji
2025-04-02
Recruiting
Peking University Third Hospital
Not applicable
400
Nanchang, Quzhou, Beijing
2025-04-02
Recruiting
Peking University First Hospital
Not applicable
1,066
Beijing, Nanning, Wuhan
2025-04-02
Recruiting
A Long-term Follow-up Study to Evaluate SKG0106 in the Treatment of Patients With nAMD
NCT06346600Neovascular (Wet) Age-related Macular Degeneration
Skyline Therapeutics
Observational
83
Hefei, Hangzhou, Wenzhou, Beijing, Shanghai
2025-04-02
By invitation
Peking University Third Hospital
Not applicable
80
Beijing
2025-04-02
Recruiting
Shunda Du
Phase 2
30
Beijing
2025-04-01
Recruiting
Pfizer
Phase 3
674
Beijing, Chongqing, Guangzhou, Changsha, Nanchang, Shanghai, Chengdu, Kunming
2025-04-01
Recruiting
Beijing Tiantan Hospital
Observational
162
Beijing
2025-04-01
Not yet open
Esketamine Combined With PRF for Trigeminal Postherpetic Neuralgia
NCT06914180Postherpetic; Neuralgia, Trigeminal (Etiology)
Beijing Tiantan Hospital
Not applicable
174
Beijing
2025-04-01
Recruiting
Peking University Cancer Hospital & Institute
Not applicable
68
Beijing
2025-04-01
Recruiting
Clinical Features, Current Treatment and Clinical Outcomes in Patients With INR-CAD: a Cohort Study
NCT06845410Coronary Artery Disease, Coronary Artery Disease Progression, Coronary Artery Stenosis, Coronary Artery Restenosis
Peking Union Medical College Hospital
Observational
120
Beijing
2025-04-01
Active, closed
Mechanisms of Macrophage Polarization in HIRI in Patients With NAFLD
NCT06950710Hepatic Ischemia-reperfusion Injury, Non-alcoholic Fatty Liver Disease
Zhifeng Gao
Observational
300
Beijing
2025-04-01
Not yet open
Beijing Tiantan Hospital
Not applicable
186
Beijing
2025-04-01
Not yet open
Wearable ECG for AF Screening and Stroke Risk Assessment
NCT06907264Atrial Fibrillation, Stroke
Beijing Tsinghua Chang Gung Hospital
Observational
243
Beijing
2025-04-01
Recruiting
CD7 CAR T-Cell Therapy for r/r T-cell Lymphomas
NCT06925464T-Cell Non-Hodgkin Lymphoma, T-cell Lymphoma (PTCL and CTCL)
Beijing GoBroad Hospital
Phase 1/2
36
Beijing, Zhanjiang, Shanghai
2025-04-01
By invitation
Da Qing Offspring Study
NCT06958640Diabetes Mellitus, Cardiovascular Diseases (CVD), Offspring, Adult, Impaired Glucose Tolerance (Prediabetes)
China-Japan Friendship Hospital
Observational
5,000
Beijing
2025-04-01
By invitation
Nanjing Medical University
Not applicable
200
Beijing, Guangzhou, Shanghai, Chengdu
2025-04-01
Active, closed
Daihong Liu
Phase 2
50
Beijing
2025-04-01
Not yet open
Beijing Tiantan Hospital
Not applicable
184
Beijing
2025-04-01
Recruiting
Allogeneic γδT Cells in Glioblastoma
NCT07144735Glioblastoma (GBM), Glioblastoma Multiforme (GBM)
Peking University Third Hospital
Not applicable
18
Beijing, Zhengzhou
2025-04-01
Recruiting
Peking Union Medical College Hospital
Observational
800
Beijing
2025-04-01
Recruiting
Prospective Study of Cadonilimab With Lenvatinib in Renal Cell Carcinoma
NCT07909265Renal Cell Carcinoma (Kidney Cancer), Clear Cell Renal Cell Carcinoma
DrugCadonilimab lenvatinib
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Phase 2
54
Beijing
2025-04-01
Active, closed
Beijing Neurosurgical Institute
Not applicable
43
Beijing
2025-04-01
Not yet open
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Observational
600
Beijing
2025-04-01
Recruiting
Beijing Tiantan Hospital
Not applicable
174
Beijing
2025-04-01
Recruiting
Beijing Tiantan Hospital
Not applicable
150
Beijing
2025-04-01
By invitation
Long-term Safety and Efficacy Study of Riliprubart in Participants With CIDP
NCT06859099Polyneuropathy, Inflammatory Demyelinating, Chronic
DrugRiliprubart
Sanofi
Phase 3
300
Beijing, Changsha, Chengdu, Fuzhou, Guangzhou, Hangzhou, Shanghai, Wuhan
2025-04-01
Not yet open
Yunhe Pharmaceutical (Tianjin) Co., Ltd
Phase 3
240
Beijing, Cangzhou, Wuhan, Yichang, Changsha, Nanjing, Suzhou, Taizhou
2025-04
Not yet open
Beijing Suncadia Pharmaceuticals Co., Ltd
Phase 1
55
Beijing
2025-04
Recruiting
Beijing Tiantan Hospital
Observational
1,000
Beijing
2025-04
Not yet open
China-Japan Friendship Hospital
Phase 4
528
Beijing
2025-04
Not yet open
Yunhe Pharmaceutical (Tianjin) Co., Ltd
Phase 3
110
Beijing, Cangzhou, Wuhan, Yichang, Changsha, Nanjing, Suzhou, Taizhou
2025-04
Recruiting
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Phase 2
170
Beijing
2025-03-31
Recruiting
Study of JYP0015 in Patients With Advanced Solid Tumors Harboring Specific Mutations in RAS
NCT06895031Solid Tumor, Pancreatic Ductal Adenocarcinoma (PDAC), Non-small Cell Lung Cancer (NSCLC), Colorectal Cancer (CRC)
Guangzhou JOYO Pharma Co., Ltd
Phase 2
210
Beijing
2025-03-31
Recruiting
China National Center for Cardiovascular Diseases
Observational
5,000
Beijing
2025-03-31
Recruiting
Peking University Cancer Hospital & Institute
Phase 2
30
Beijing
2025-03-31
Active, closed
Shanghai Yinnuo Pharmaceutical Technology Co., Ltd.
Phase 2/3
1,003
Beijing, Changzhou, Chengdu, Guangzhou, Guangzhusi, Guizhou, Hangzhou, Harbin
2025-03-31
Not yet open
Peking Union Medical College Hospital
Not applicable
600
Beijing
2025-03-31
Not yet open
Application-Assisted Weight Management in Endometrial Cancer Fertility Preservation
NCT06901778Endometrial Cancer, Mobile Applications, Weight Management
Peking University People's Hospital
Not applicable
106
Beijing
2025-03-31
Recruiting
Gritgen Therapeutics Co., Ltd.
Phase 3
50
Hefei, Beijing, Lanzhou, Guangzhou, Tangshan, Zhengzhou, Wuhan, Changsha
2025-03-31
Not yet open
Pulmonary Deposition of Ultrasound Rock Salt Aerosol Inhalation Therapy
NCT06891274COPD, Asthma Bronchiale, Chronic Bronchitis
Jingen Xia
Not applicable
26
Beijing
2025-03-31
Recruiting
Shanghai Qilu Pharmaceutical Research and Development Center LTD
Phase 1
102
Beijing
2025-03-31
Not yet open
Beijing Anzhen Hospital
Observational
10,000
Beijing
2025-03-30
Not yet open
Peking Union Medical College Hospital
Observational
1,138
Beijing
2025-03-30
Recruiting
Peking University People's Hospital
Not applicable
20
Beijing
2025-03-29
Recruiting
Long-term Evaluation of Gestational Endocrine & Metabolic Dynamics
NCT07119177Gestational Diabetes Mellitus (GDM), Non-communicable Chronic Diseases
Yang ZHANG
Observational
800
Beijing
2025-03-29
Recruiting
Li Xiang
Not applicable
72
Beijing
2025-03-28
Recruiting
Beijing Tiantan Hospital
Phase 1
10
Beijing
2025-03-28
Recruiting
AstraZeneca
Phase 3
600
Beijing, Changchun, Changsha, Chengdu, Chongqing, Fuzhou, Guangzhou, Haikou
2025-03-27
Active, closed
Suzhou Genhouse Bio Co., Ltd.
Phase 1
126
Beijing, Shanghai
2025-03-27
Recruiting
One Trial to Evaluate the Safety, Tolerability and Efficacy of JCXH-213 in Patients With r/r B-NHL
NCT06618313B-Cell Non-Hodgkin Lymphoma-Recurrent, B-Cell Non-Hodgkin Lymphoma-Refractory
Beijing GoBroad Hospital
Not applicable
8
Beijing
2025-03-27
Recruiting
Eli Lilly and Company
Phase 3
700
Anyang, Beijing, Changchun, Changsha, Chengdu, Chongqing, Foshan, Guangzhou
2025-03-27
Recruiting
Daiichi Sankyo
Phase 3
510
Anyang, Beijing, Changchun, Changzhou, Chengdu, Fuzhou, Hangzhou, Harbin
2025-03-27
Active, closed
A Study of IBI362 in Subjects With HFpEF or HFmrEF Combined With Obesity
NCT06862908Obesity, Heart Failure With Preserved Ejection Fraction (HFPEF), Heart Failure With Mildly Reduced Ejection Fraction
DrugMazdutide
Innovent Biologics (Suzhou) Co. Ltd.
Phase 2
141
Beijing
2025-03-26
Recruiting
Daihong Liu
Phase 1
18
Beijing
2025-03-26
Not yet open
LaNova Medicines Limited
Phase 2
84
Beijing
2025-03-26
Recruiting
Merck Sharp & Dohme LLC
Phase 1/2
270
Beijing, Chongqing, Changsha, Changchun, Chengdu
2025-03-25
Not yet open
Peking Union Medical College Hospital
Not applicable
116
Beijing
2025-03-25
Recruiting
Liquid Biopsy-Based Novel Modality for Postoperative Management of Lung Cancer
NCT06930807Non-small Cell Lung Cancer, Minimal Residual Disease, Adaptive Treatment
Peking University People's Hospital
Not applicable
1,000
Beijing
2025-03-25
Active, closed
Autologous Fecal Microbiota Transplantation for Anal Function Recovery After Ileostomy Reversal in Rectal Cancer
NCT07711509Rectal Cancer, Low Anterior Resection Syndrome, Fecal Incontinence, Diversion Colitis
Peking University People's Hospital
Not applicable
35
Beijing
2025-03-25
Recruiting
Peking Union Medical College Hospital
Early Phase 1
20
Beijing
2025-03-24
Recruiting
Beijing Tiantan Hospital
Observational
840
Beijing
2025-03-24
Recruiting
Intermittent Theta Burst Stimulation on Cognitive Impairment of Cerebral Small Vessel Disease
NCT06579664Cerebral Small Vessel Diseases, Cognitive Impairment
Beijing Tiantan Hospital
Not applicable
58
Beijing
2025-03-24
Recruiting
The Efficacy of Modified Olfactory Training Method for Patients With Post-viral Olfactory Dysfunction
NCT06829706Olfactory Dysfunction, Post Viral Olfactory Dysfunction (PVOD)
Peking University Third Hospital
Not applicable
150
Beijing
2025-03-22
Not yet open
The Efficacy of Modified Olfactory Training for MCI High-Risk Individuals
NCT06821828Subjective Cognitive Decline (SCD), Olfactory Dysfunction, Mild Cognitive Impairment (MCI), ELDERLY PEOPLE
Peking University Third Hospital
Not applicable
114
Beijing
2025-03-22
Recruiting
Beijing Anzhen Hospital
Not applicable
176
Beijing
2025-03-21
Recruiting
Bayer
Phase 1/2
450
Beijing, Wuhan, Nanjing, Hangzhou
2025-03-21
Recruiting
Riociguat-Discontinue Effects on Right HEART in CTEPH (RED-HEART)
NCT06922240Chronic Thromboembolic Pulmonary Hypertension
DrugRiociguat
Suqiao Yang
Phase 3
68
Beijing
2025-03-21
Recruiting
Peking University Cancer Hospital & Institute
Phase 2
57
Beijing
2025-03-21
Recruiting
Shanghai Chia Tai Tianqing Pharmaceutical Technology Development Co., Ltd.
Phase 3
660
Bozhou, Hefei, Lu'an, Tongling, Beijing, Xiamen, Zhangzhou, Lanzhou
2025-03-21
Recruiting
Beijing Tiantan Hospital
Phase 2
192
Beijing
2025-03-21
Active, closed
Jian Li
Phase 1
30
Beijing, Hohhot, Shanghai
2025-03-20
Recruiting
Shanghai Mabgeek Biotech.Co.Ltd
Phase 2/3
160
Beijing
2025-03-20
Recruiting
Chinese PLA General Hospital
Not applicable
70
Beijing
2025-03-20
Recruiting
Beijing InnoCare Pharma Tech Co., Ltd.
Phase 3
383
Hefei, Wuhu, Beijing, Chongqing, Fuzhou, Guangzhou, Liuzhou, Guiyang
2025-03-20
Not yet open
Peking Union Medical College Hospital
Not applicable
332
Beijing
2025-03-20
Active, closed
Ye Zhiyin
Not applicable
120
Beijing
2025-03-20
Recruiting
Daiichi Sankyo
Phase 3
582
Beijing, Changchun, Changsha, Chengdu, Chongqing, Dalian, Fuzhou, Guangzhou
2025-03-19
Active, closed
The Correction of Midface Volume Deficiency and/or Midface Contour Deficiency
NCT07359079the Correction of Midface Volume Deficiency and/or Midface Contour Deficiency
Chongqing Jinsaixing Medical Technology Co., Ltd
Not applicable
356
Beijing
2025-03-19
Recruiting
Chinese PLA General Hospital
Phase 1
25
Beijing
2025-03-19
Recruiting
Beijing Tsinghua Chang Gung Hospital
Observational
6,000
Beijing
2025-03-19
Recruiting
Peking University First Hospital
Observational
200
Beijing
2025-03-19
Recruiting
AstraZeneca
Phase 3
990
Anyang, Beijing, Changchun, Changsha, Chengdu, Chongqing, Fuzhou, Guangzhou
2025-03-18
Recruiting
A Study of BGB-B455 in Adults With Advanced or Metastatic Solid Tumors
NCT06803680Advanced Solid Tumor, Metastatic Solid Tumor
BeOne Medicines
Phase 1
90
Beijing, Nanchang, Shanghai, Taiyuan
2025-03-18
Active, closed
Concomitant Left Atrial Appendage Closure and Pulsed Field Ablation-Asia
NCT06686485Concomitant Procedures, Atrial Fibrillation, PFA, LAAC
Boston Scientific Corporation
Observational
433
Suzhou, Beijing, Chengdu, Guangzhou, Guiyang, Hangzhou, Jinan, Kunming
2025-03-18
Recruiting
Peking University First Hospital
Phase 4
476
Beijing
2025-03-18
Recruiting
Peking Union Medical College Hospital
Observational
318
Beijing
2025-03-18
Active, closed
Guangzhou Medical University
Phase 1/2
39
Beijing, Huizhou, Shanghai
2025-03-17
Active, closed
Beijing HuiLongGuan Hospital
Not applicable
200
Beijing
2025-03-17
Recruiting
Jiangsu vcare pharmaceutical technology co., LTD
Phase 3
54
Beijing
2025-03-17
Active, closed
Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd.
Phase 2
256
Hefei, Beijing, Chongqing, Foshan, Jiangmen, Liuzhou, Yulin, Cangzhou
2025-03-17
Recruiting
Hoffmann-La Roche
Phase 3
600
Beijing, Changchun, Changsha, Chengdu, Chongqing, Fuzhou, Guangzhou, Hangzhou
2025-03-17
Recruiting
The Effect of VitC on IVF Outcome of DOR Patients
NCT06794047Diminished Ovarian Reserve, IVF Outcomes
Peking University Third Hospital
Not applicable
1,100
Beijing, Shijiazhuang, Yinchuan, Xi’an, Shenzhen
2025-03-17
Not yet open
Xin Lou
Observational
1,000
Beijing
2025-03-16
By invitation
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Observational
250
Beijing
2025-03-15
Not yet open
Peking University Third Hospital
Not applicable
20
Beijing
2025-03-15
Recruiting
Geneplus-Beijing Co. Ltd.
Observational
200
Beijing
2025-03-15
Not yet open
Peking University
Not applicable
120
Beijing
2025-03-15
Recruiting
Beijing Tongren Hospital
Phase 1
16
Beijing
2025-03-15
Recruiting
Longitudinal Cohort Study on Invasive Fungal Disease After Allogeneic Hematopoietic Stem Cell Transplantation
NCT07569055Invasive Fungal Disease, Allogeneic Hematopoietic Stem Cell Transplantation (HSCT)
Peking University People's Hospital
Observational
6,000
Beijing
2025-03-15
Not yet open
Peking University Third Hospital
Not applicable
213
Beijing
2025-03-14
Recruiting
AstraZeneca
Phase 3
11,300
Baotou, Beijing, Changchun, Changde, Changsha, Changzhou, Chengdu, Chifeng
2025-03-14
Active, closed
Hoffmann-La Roche
Phase 4
274
Beijing, Chengdu, Guangzhou, Shanghai, Wuhan
2025-03-14
Not yet open
Peking University Third Hospital
Observational
80
Beijing
2025-03-14
Active, closed
RemeGen Co., Ltd.
Phase 1
121
Beijing, Foshan, Guangzhou, Jiangmen, Gulin, Nanning, Harbin, Hanyang
2025-03-13
Recruiting
Hansoh BioMedical R&D Company
Phase 3
468
Beijing
2025-03-13
Recruiting
Jemincare
Phase 2
135
Beijing
2025-03-13
Recruiting
RenJi Hospital
Observational
114
Beijing, Guangdong, Guizhou, Jiangsu, Shanghai, Sichuan, Tianjin, Zhejiang
2025-03-13
Recruiting
Xuanwu Hospital, Beijing
Observational
622
Beijing
2025-03-13
Recruiting
Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd.
Phase 2
170
Beijing, Chongqing, Fuzhou, Lanzhou, Guangzhou, Meizhou, Qingyuan, Nanning
2025-03-13
Recruiting
Bristol-Myers Squibb
Phase 3
60
Beijing, Chongqing, Guangzhou, Nanjing, Changchun, Hangzhou, Shanghai
2025-03-13
Active, closed
Celgene
Phase 3
960
Hefei, Beijing, Fuzhou, Xiamen, Guangzhou, Huizhou, Changzhou, Nanjing
2025-03-13
Recruiting
A Long-term Follow up Study of EXG102-031 in Participants With wAMD
NCT06859515Wet Age-related Macular Degeneration
Guangzhou Jiayin Biotech Ltd
Observational
42
Beijing
2025-03-13
Recruiting
Managing Pregnancy Pain With Baduanjin Exercise
NCT07153653Pregnancy-related Low Back and Pelvic Pain, Pregnancy
Peking Union Medical College Hospital
Not applicable
84
Beijing
2025-03-13
Active, closed
AstraZeneca
Phase 2
82
Beijing
2025-03-12
Recruiting
Pfizer
Phase 3
723
Beijing, Chongqing, Shijiazhuang, Nanjing, Suzhou, Xi'an, Xianyang, Shanghai
2025-03-11
Recruiting
Peking University Third Hospital
Observational
600
Beijing
2025-03-11
Recruiting
A Study of SRSD107 in Participants With Chronic Coronary and/or Peripheral Arterial Disease
NCT07318155Coronary Artery Disease (CAD), Peripheral Arterial Disease
DrugSRSD107
Sirius Therapeutics Co., Ltd.
Phase 2
104
Beijing
2025-03-11
Recruiting
China-Japan Friendship Hospital
Not applicable
158
Beijing
2025-03-11
Active, closed
Takeda
Phase 3
601
Bengbu, Beijing, Xiamen, Guangzhou, Shenzhen, Luoyang, Wuhan, Zhuzhou
2025-03-10
Recruiting
Beijing Tiantan Hospital
Not applicable
40
Beijing
2025-03-10
Not yet open
Peking University
Phase 1
48
Beijing, Nanjing
2025-03-10
Active, closed
Hangzhou Highlightll Pharmaceutical Co., Ltd
Phase 3
350
Beijing
2025-03-10
Not yet open
Peking University People's Hospital
Phase 2
30
Beijing
2025-03-10
Recruiting
The Clinical Study of Synaptic Plasticity-based Lencanumab for the Treatment of Early Alzheimer's Disease
NCT06871839Alzheimer's Disease, Lecanemab, Functional Magnetic Resonance Imaging
Cuibai Wei，Clinical Professor
Observational
120
Beijing
2025-03-10
Recruiting
Study of YK012 in Primary Membranous Nephropathy
NCT06982729Primary Membranous Nephropathy
DrugYK012
Excyte Biopharma Ltd
Phase 1
72
Beijing
2025-03-08
Recruiting
Electroacupuncture Treatment for Discogenic Low Back Pain
NCT06703671Discogenic Low Back Pain
Beijing Hospital
Not applicable
240
Beijing
2025-03-08
Active, closed
Guangzhou Medical University
Phase 1/2
39
Huizhou, Beijing, Shanghai
2025-03-07
Recruiting
Carotid Endarterectomy and Stenting Timing
NCT06898151Carotid Endarterectomy, Carotid Stenting
Xuanwu Hospital, Beijing
Not applicable
268
Beijing
2025-03-07
Recruiting
Suzhou Suncadia Biopharmaceuticals Co., Ltd.
Phase 2
300
Beijing
2025-03-07
Recruiting
Suzhou Genhouse Bio Co., Ltd.
Phase 1
200
Beijing, Fuzhou, Xiamen, Lanzhou, Guangzhou, Nanning, Guiyang, Zhengzhou
2025-03-07
Not yet open
A Trial to Evaluate KPC000154 Tablets in Healthy Subjects
NCT06867406Healthy Subjects、Lipid Metabolism
Kunming Pharmaceuticals, Inc.
Phase 1
92
Beijing
2025-03-07
Recruiting
AbbVie
Phase 1/2
252
Beijing, Fuzhou, Liuzhou, Zhengzhou, Wuhan, Changsha, Nanjing, Nanchang
2025-03-06
Active, closed
Effect of Terlipressin for Intraoperative Blood Pressure Management in Kidney Transplantation
NCT06855758Kidney Transplant, Delayed Graft Function, Intraoperative Hypotension
DrugTerlipressin
Beijing Friendship Hospital
Not applicable
150
Beijing
2025-03-06
Recruiting
BeOne Medicines
Phase 3
300
Beijing, Chongqing, Guangzhou, Harbin, Zhengzhou, Wuhan, Nanjing, Xuzhou
2025-03-05
Recruiting
Peking University
Phase 1
78
Beijing, Shanghai
2025-03-04
Recruiting
China National Center for Cardiovascular Diseases
Phase 4
356
Beijing
2025-03-04
Recruiting
AstraZeneca
Phase 3
5,000
Baotou, Beijing, Changchun, Changsha, Changzhou, Chengdu, Chongqing, Dongwan
2025-03-03
Recruiting
Beijing Tiantan Hospital
Not applicable
4,490
Beijing, Shihezi
2025-03-03
Recruiting
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Phase 2
102
Beijing
2025-03-01
By invitation
Beijing Chao Yang Hospital
Not applicable
308
Beijing
2025-03-01
Not yet open
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Phase 3
400
Beijing
2025-03-01
Not yet open
Tsinghua University
Not applicable
100
Beijing
2025-03-01
Recruiting
Peking University Cancer Hospital & Institute
Early Phase 1
3
Beijing
2025-03-01
Recruiting
Peking University People's Hospital
Not applicable
68
Beijing
2025-03-01
Recruiting
China-Japan Friendship Hospital
Not applicable
200
Beijing
2025-03-01
Active, closed
Peking University People's Hospital
Not applicable
105
Beijing, Zhengzhou
2025-03-01
Recruiting
Juventas Cell Therapy Ltd.
Phase 1
12
Beijing
2025-03-01
Not yet open
Effects of GLP-1RAs on Reproductive Outcomes in PCOS and Obesity
NCT06775093Polycystic Ovary Syndrome, Obesity, Infertility, Female
DrugMetformin
Peking University Third Hospital
Not applicable
392
Beijing
2025-03-01
Recruiting
Peking Union Medical College Hospital
Phase 1
18
Beijing
2025-03-01
Recruiting
rhTNK-tPA Thrombolytic Removal of Intraventricular Hemorrhage
NCT06814964Intraventricular Hemorrhage
Beijing Tiantan Hospital
Phase 1
18
Beijing
2025-03-01
Recruiting
Acupuncture for Prediabetes With Combined Obesity
NCT06359418Obesity, Abdominal Obesity, PreDiabetes
Guang'anmen Hospital of China Academy of Chinese Medical Sciences
Not applicable
260
Beijing
2025-03-01
Recruiting
Peking University Cancer Hospital & Institute
Phase 2
63
Beijing
2025-03-01
Not yet open
Allogeneic B7H3 CAR-γδT Cell Therapy for Advanced Solid Tumors
NCT06825455Advanced Solid Tumors, Ovarian Cancers, Peritoneal (metastatic) Cancer
DrugsFludarabine·Cyclophosphamide
Peking University
Early Phase 1
18
Beijing
2025-03-01
Not yet open
Inflammatory and Metabolic Prognostic Assessment in Critically Ill Neurological Patients
NCT06849011Stroke Acute, Encephalitis, Non-traumatic Brain Injury
Yan Zhang
Observational
1,185
Beijing, Lanzhou, Guiyang, Zunyi, Tangshan, Shijiazhuang, Hohhot, Suzhou
2025-03-01
Recruiting
Electroencephalogram Predicts Post-operative Delirium
NCT06894238Neurosurgery, Delirium - Postoperative, Brain Tumor Adult
Beijing Sanbo Brain Hospital
Observational
137
Beijing
2025-03-01
Not yet open
A Multicenter Prospective Study of Iptacopan in the Treatment of Refractory/Relapsed Autoimmune Hemolytic Anemia (AIHA)
NCT06847607AIHA - Warm Autoimmune Hemolytic Anemia, AIHA - Cold Autoimmune Hemolytic Anemia
DrugIptacopan
Bing Han
Not applicable
20
Beijing
2025-03-01
Recruiting
Runhui WU
Phase 4
110
Beijing
2025-03-01
Recruiting
Study of SYH2062 Injection in Healthy Chinese Volunteers
NCT06842537Healthy Chinese Volunteers
CSPC Zhongnuo Pharmaceutical (Shijiazhuang) Co., Ltd.
Phase 1
46
Beijing
2025-03-01
Recruiting
Juventas Cell Therapy Ltd.
Early Phase 1
18
Beijing
2025-03-01
Recruiting
Capital Medical University
Not applicable
80
Beijing
2025-03-01
Recruiting
Trop-2 Targeted PET Probes in Advanced TNBC
NCT07046455TNBC - Triple-Negative Breast Cancer
DrugSacituzumab Govitecan
Peking University Cancer Hospital & Institute
Not applicable
20
Beijing
2025-03-01
Recruiting
Investigation of Tetralogy of Fallot in Neonates
NCT06822400Tetralogy of Fallot (TOF), Pulmonary Stenosis, Ventricular Septal Defects (VSD), Double Outlet Right Ventricle
Beijing Anzhen Hospital
Not applicable
160
Beijing, Chengdu, Shanghai, Shenzhen, Suzhou
2025-03-01
Recruiting
Yishen Shujin Decoction for Fibromyalgia Syndrome
NCT07555691Fibromyalgia Syndrome
Juan Jiao
Not applicable
100
Beijing
2025-03-01
Recruiting
AstraZeneca
Phase 3
840
Anyang, Beijing, Bengbu, Changchun, Changsha, Chengdu, Fuzhou, Guangzhou
2025-03-01
Recruiting
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Observational
100
Beijing
2025-03-01
Active, closed
Chang Zhou
Observational
25
Beijing
2025-03-01
Recruiting
The Disease Progression of Chinese Axial Spondyloarthritis in a Real-word Cohort Study
NCT06844643Axial Spondyloarthritis, Ankylosing Spondylitis (AS)
China-Japan Friendship Hospital
Observational
2,250
Beijing
2025-03-01
Recruiting
Clinical Analgesic Management in Dementia
NCT07323914Alzheimer Disease
Xuanwu Hospital, Beijing
Phase 3
10
Beijing
2025-03-01
Recruiting
Assessing the Performance of GPT-4o in Evaluating the Safety of Home Environment for Older Adults
NCT06962696Elderly (People Aged 65 or More), Home Environment Related Disease
Peking University Third Hospital
Observational
20
Beijing
2025-03-01
Recruiting
Jian-Xin Zhou
Not applicable
20
Beijing
2025-03-01
Recruiting
KPD Consolidation After ASCT in NDMM Patients
NCT06879379Multiple Myeloma, Newly Diagnosed
Peking University People's Hospital
Phase 2/3
202
Beijing, Shanghai
2025-03
Not yet open
Ahon Pharmaceutical Co., Ltd.
Phase 3
270
Beijing, Shenzhen, Chengdu, Guangyuan, Yibin
2025-03
Not yet open
YIN LI
Phase 2/3
474
Beijing
2025-03
Not yet open
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Phase 2
120
Bengbu, Hefei, Beijing, Lanzhou, Guangzhou, Shenzhen, Nanning, Langfang
2025-03
Recruiting
Sichuan Luzhou Buchang Biopharmaceutical Co., Ltd.
Phase 1
80
Beijing
2025-02-28
Not yet open
Familial Breast Cancer in China
NCT06833216Breast Carcinoma, Genetic Variation
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Observational
500
Beijing
2025-02-28
Not yet open
Universal CAR-T Cells in Patients with Refractory Autoimmune Diseases of the Nervous System.
NCT06485232Neuromyelitis Optica Spectrum Disorders, Myasthenia Gravis, Generalized, Multiple Sclerosis, Chronic Inflammatory Demyelinating Polyradiculoneuropathy
Xuanwu Hospital, Beijing
Early Phase 1
25
Beijing
2025-02-28
Active, closed
A Phase 2 in Adult Subjects With Hereditary Angioedema
NCT06846398Hereditary Angioedema (HAE)
DrugBW-20805
Shanghai Argo Biopharmaceutical Co., Ltd.
Phase 2
25
Beijing, Lanzhou, Wuhan, Yantai, Chengdu, Kunming
2025-02-28
Recruiting
Novartis Pharmaceuticals
Phase 3
9
Beijing
2025-02-28
Recruiting
Peking University Third Hospital
Not applicable
250
Beijing
2025-02-28
Recruiting
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Phase 2
61
Beijing
2025-02-28
Recruiting
Merck Sharp & Dohme LLC
Phase 1/2
327
Beijing, Fuzhou, Nanjing, Shanghai, Chengdu, Hangzhou
2025-02-27
Recruiting
Novartis Pharmaceuticals
Phase 2/3
443
Fuzhou, Wuhan, Nanjing, Shenyang, Xian, Chengdu, Beijing, Guangzhou
2025-02-27
Recruiting
CSPC Baike (Shandong) Biopharmaceutical Co., Ltd.
Phase 1
66
Beijing
2025-02-27
Recruiting
Daiichi Sankyo
Phase 3
726
Beijing, Changzhou, Fuzhou, Hangzhou, Harbin, Hefei, Jinan, Lanzhou
2025-02-27
Recruiting
Tasly Pharmaceutical Group Co., Ltd
Phase 3
342
Beijing, Lanzhou, Guiyang, Shijiazhuang, Xingtai, Baoding, Luoyang, Changchun
2025-02-27
Recruiting
Alebund Pharmaceuticals
Phase 1
18
Beijing
2025-02-27
Recruiting
Summit Therapeutics
Phase 3
780
Fuyang, Beijing, Fuzhou, Guangzhou, Nanning, Guiyang, Haikou, Harbin
2025-02-27
Recruiting
Daiichi Sankyo
Observational
260
Beijing, Changchun, Changzhi, Fuzhou, Guangzhou, Haikou, Hangzhou, Hefei
2025-02-27
Recruiting
Takeda
Phase 3
171
Beijing, Guangzhou, Nanning, Shijiazhuang, Wuhan, Zhengzhou, Suzhou, Nanchang
2025-02-27
Recruiting
Shanghai Mabgeek Biotech.Co.Ltd
Phase 3
160
Beijing
2025-02-26
Recruiting
Effect of Reduced Vasopressors on Mortality in ECMO-supported Cardiogenic Shock Patients
NCT06862700Cardiogenic Shock, Extracorporeal Membrane Oxygenation, Vasopressors, Hemodynamic Management
Xiaotong Hou
Observational
534
Beijing
2025-02-26
Recruiting
Qurgen Inc.
Phase 1
96
Beijing, Lanzhou, Guangzhou, Nanjing, Xi'an, Jinan, Shanghai, Hangzhou
2025-02-26
Recruiting
A Phase I Study of SIM0505 in Participants With Advanced Solid Tumors
NCT06792552Advanced Solid Tumors, Platinum Resistant Ovarian Cancer, Fallopian Tube Cancer, Renal Cell Carcinoma (RCC)
NextCure, Inc.
Phase 1
738
Beijing, Shenyang, Shijiazhuang, Guangzhou, Changsha, Jinan, Jining, Shanghai
2025-02-26
Active, closed
Amgen
Phase 2
252
Beijing, Fuzhou, Guangzhou, Harbin, Changsha, Taiyuan, Chengdu, Tianjin
2025-02-26
Recruiting
Lepu Medical Technology (Beijing) Co., Ltd.
Not applicable
213
Beijing, Chongqing, Xiamen, Lanzhou, Shenzhen, Zhengzhou, Hohhot, Yinchuan
2025-02-25
Recruiting
Peking University Cancer Hospital & Institute
Observational
65
Beijing
2025-02-25
Recruiting
Bristol-Myers Squibb
Phase 3
530
Beijing, Chongqing, Fuzhou, Xiamen, Shantou, Harbin, Wuhan, Changsha
2025-02-25
Recruiting
Xuanwu Hospital, Beijing
Phase 2
10
Beijing
2025-02-24
Recruiting
CStone Pharmaceuticals
Phase 1/2
800
Beijing, Changchun, Changsha, Chengdu, Fuzhou, Guangzhou, Hangzhou, Harbin
2025-02-24
Not yet open
Effects of Exercise Snacks and Sprint Interval Training in Overweight Adults
NCT06849453Cardiovascular Function, Cardiorespiratory Fitness
Beijing Sport University
Not applicable
45
Beijing
2025-02-24
Active, closed
Chongqing Jinsaixing Medical Technology Co., Ltd
Not applicable
356
Beijing
2025-02-24
Recruiting
Zhejiang Sunshine Mandi Pharmaceutical Co.,Ltd.
Phase 3
294
Beijing
2025-02-24
Active, closed
Innovent Biologics (Suzhou) Co. Ltd.
Phase 2
203
Hefei, Beijing, Chongqing, Fuzhou, Guangzhou, Nanning, Shijiazhuang, Harbin
2025-02-24
Recruiting
Shanghai Pushi Medical Science Co. Ltd
Phase 1
66
Beijing, Fujian, Zhejiang, Heilongjiang, Shandong, Guangdong, Shenyang, Hebei
2025-02-24
Recruiting
Peking University
Phase 1
44
Beijing
2025-02-24
Recruiting
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Early Phase 1
83
Beijing
2025-02-24
Recruiting
The Cohort Construction Project of Peking University Third Hospital
NCT07761676Multiple Chronic Conditions (Unspecified), Large-scale Health Examination Cohort
Peking University Third Hospital
Observational
100,000
Beijing
2025-02-21
Recruiting
CD123-CD16-NK Cells Immunotherapy for AML
NCT06835140AML (Acute Myelogenous Leukemia), NK Cell, CD123+ Acute Myeloid Leukemia
Chunji Gao
Phase 1
9
Beijing
2025-02-21
Active, closed
Janssen Research & Development, LLC
Phase 3
552
Beijing, Changchun, Changsha, Chengdu, Chongqing, Guangzhou, Guiyang, Linyi
2025-02-21
Recruiting
Tianjin Institute of Pharmaceutical Research Co., Ltd
Phase 2
600
Shenyang, Beijing
2025-02-21
Recruiting
Daiichi Sankyo
Observational
150
Beijing, Changsha, Fuzhou, Guangdong, Guangzhou, Hangzhou, Hebei, Hefei
2025-02-21
Recruiting
Beijing GoBroad Hospital
Phase 1
27
Beijing
2025-02-20
Not yet open
Jian-Xin Zhou
Not applicable
20
Beijing
2025-02-20
Recruiting
Peking Union Medical College Hospital
Phase 2
300
Beijing
2025-02-19
Recruiting
IBSA Farmaceutici Italia Srl
Not applicable
500
Beijing, Changde, Chengdu, Shanghai, Xi'an
2025-02-19
Not yet open
Efficacy and Safety of AL-001 Ophthalmic Injection in Subjects with WAMD
NCT06839339Wet Age-related Macular Degeneration (wAMD)
DrugsAL-001·Aflibercept
Beijing Anlong Biopharmaceutical Co., Ltd.
Phase 2
40
Beijing
2025-02-18
Active, closed
KRAS-Specific Autologous TCR-T Cell Therapy for KRAS Mutation in Advanced Solid Tumors
NCT06767046Colorectal, Pancreatic, Non-small Cell Lung Cancer (NSCLC)
Corregene Biotechnology Co., Ltd
Phase 1
8
Beijing
2025-02-18
Recruiting
Echocardiography Guided TAVR (Echo TAVR)
NCT07030062Transcatheter Aortic Valve Replacemen, Echocardiography
Pan Xiangbin
Observational
20
Beijing
2025-02-18
Not yet open
ExCR's Effects and Safety in Vulnerable ADHF Patients
NCT06795737Acute Decompensated Heart Failure (ADHF)
YE Jing
Not applicable
88
Beijing
2025-02-17
Not yet open
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Phase 2
30
Beijing
2025-02-15
Recruiting
Chinese PLA General Hospital
Phase 1/2
30
Beijing, Changzhi, Tianjin
2025-02-15
Not yet open
Pulsed Field Ablation Versus Radiofrequency Ablation for Persistent Atrial Fibrillation
NCT06791629Persistent Atrial Fibrillation, Radiofrequency Catheter Ablation, Pulsed Field Ablation
Beijing Anzhen Hospital
Not applicable
700
Beijing
2025-02-15
Not yet open
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Not applicable
9
Beijing
2025-02-15
Recruiting
Nanobody-Based Anti-CD5 CAR-T for Relapsed/Refractory T-ALL/NHL
NCT06874946Precursor T-Cell Lymphoblastic Leukemia-Lymphoma, T - Cell Lymphoma, PTCL
Peking University People's Hospital
Phase 1/2
30
Beijing
2025-02-14
Recruiting
A Study of CSCJC3456 in Patients With Advanced Malignant Tumors
NCT06717750Advanced Malignant Solid Tumors
Changshan ConjuChem BioPharmaceutical Research and Development (Hebei) Co., Ltd.
Phase 1
102
Beijing, Shenyang
2025-02-13
By invitation
Beijing Anzhen Hospital
Observational
49
Beijing
2025-02-13
Recruiting
Bayer
Phase 2
111
Beijing, Changsha, Shanghai, Hangzhou
2025-02-13
Recruiting
Efficacy of Thermal Ablation Combined With Antithyroid Drugs in the Treatment of Primary Hyperthyroidism
NCT07557810Complication Rate, Efficacy and Safety, Hyperthyroidism/Thyrotoxicosis, Cure Rate
Chinese PLA General Hospital
Observational
454
Beijing
2025-02-13
Recruiting
Shanghai Hengrui Pharmaceutical Co., Ltd.
Phase 3
402
Beijing
2025-02-12
By invitation
Longboard Pharmaceuticals
Phase 3
324
Beijing, Guangzhou, Shenzhen Shi, Wuhan, Shanghai Shi
2025-02-12
By invitation
Xiaorong Wu
Phase 1/2
40
Beijing
2025-02-12
Recruiting
Beijing Friendship Hospital
Phase 2
52
Beijing
2025-02-11
Active, closed
AbbVie
Phase 3
468
Beijing, Guangzhou, Shijiazhuang, Wuhan, Suzhou, Xi'an, Taiyuan, Tianjin
2025-02-10
Recruiting
Kai Hu
Phase 1
24
Beijing
2025-02-10
Recruiting
Study on the Treatment of Nonthrombotic Obstructive Pulmonary Hypertension
NCT06980584Fibrosing Mediastinitis, Pulmonary Hypertension
Beijing Chao Yang Hospital
Not applicable
48
Beijing
2025-02-10
Recruiting
RemeGen Co., Ltd.
Phase 2
40
Beijing
2025-02-10
Recruiting
Goal-directed Hemodynamic Management and Kidney Injury After Radical Nephrectomy or Nephroureterectomy
NCT05149196Nephrectomy, Nephroureterectomy, Hemodynamic Management, Acute Kidney Injury
Peking University First Hospital
Not applicable
1,724
Beijing
2025-02-10
Recruiting
Chinese Rheumatism Biobank(CRB)
NCT06887517Lupus Erythematosus, Systemic
Chinese SLE Treatment And Research Group
Observational
300
Beijing
2025-02-10
Recruiting
Epidural Spinal Cord Stimulation for Lower-limb Impairment in Adrenomyeloneuropathy
NCT06796920Adrenomyeloneuropathy Without Cerebral Involvement
Third Military Medical University
Not applicable
10
Beijing, Chongqing, Jingmen
2025-02-10
Active, closed
Testing the Effectiveness of AI Chatbots to Improve Public Knowledge and Attitudes Towards Depression
NCT06858371Depression Literacy, Depression Disorders, Stigma of Mental Illness
Peking University
Not applicable
200
Beijing
2025-02-10
Recruiting
Dianthus Therapeutics
Phase 3
256
Hefei, Guangzhou, Changsha, Chifeng, Suzhou, Beijing, Chengdu, Fujian
2025-02-10
Not yet open
Clinical Classification of MAFLD Based Liver Biopsy
NCT06795646Metabolic Dysfunction Associated Steatotic Liver Disease, Metabolic Dysfunction-associated Steatohepatitis (MASH)
Beijing Friendship Hospital
Observational
2,000
Beijing, Hangzhou, Shanghai, Tianjin
2025-02-08
Recruiting
Beijing Tiantan Hospital
Not applicable
552
Beijing
2025-02-08
Recruiting
China National Center for Cardiovascular Diseases
Observational
1,845
Beijing
2025-02-08
Recruiting
Beijing Visionly Plus Eye Hospital
Not applicable
1,000
Beijing
2025-02-08
Active, closed
Novartis Pharmaceuticals
Phase 3
180
Hefei, Guangzhou, Shijiazhuang, Zhengzhou, Wuhan, Wuxi, Changchun, Beijing
2025-02-07
Recruiting
Shanghai NK Cell Technology Co., LTD
Phase 1
76
Beijing
2025-02-07
Recruiting
The Efficacy and Safety of HRS8179 in Severe Cerebral Edema Following Large Hemispheric Infarction
NCT06732648Severe Cerebral Edema Following Large Hemispheric Infarction
Beijing Suncadia Pharmaceuticals Co., Ltd
Phase 2/3
725
Beijing
2025-02-07
Recruiting
Akeso
Phase 3
416
Beijing
2025-02-07
Active, closed
Sanofi
Phase 3
216
Baotou, Beijing, Chengdu, Chongqing, Hangzhou, Jinan, Jingzhou, Nanning
2025-02-06
Recruiting
RNS for Treatment-resistant Obsessive-compulsive Disorder
NCT06782867Obsessive-Compulsive Disorder (OCD)
Xuanwu Hospital, Beijing
Not applicable
10
Beijing
2025-02-05
Not yet open
The Efficacy and Safety of Chiglitazar in Patients with MAFLD-related Cirrhosis
NCT06773221Metabolic Dysfunction Associated Fatty Liver Disease, Compensated Liver Cirrhosis
DrugChiglitazar
Beijing Friendship Hospital
Not applicable
195
Beijing
2025-02-05
Recruiting
LEO Pharma
Phase 3
90
Beijing, Changchun, Changsha, Chengdu, Hangzhou, Jinan, Shanghai, Shenzhen
2025-02-05
Recruiting
Xuanwu Hospital, Beijing
Not applicable
10
Beijing
2025-02-05
Recruiting
BioNTech SE
Phase 3
621
Changchun, Baoding, Beijing, Bengbu, Fuzhou, Guangzhou, Hangzhou, Ha’erbin
2025-02-03
Recruiting
Efficacy and Central Mechanisms of Electroacupuncture for Medication Overuse Headache
NCT06802471Medication Overuse Headache, Electroacupuncture
Guang'anmen Hospital of China Academy of Chinese Medical Sciences
Not applicable
160
Beijing
2025-02-01
Not yet open
A Multicenter Study of Artificial Intelligence Model for Fetal Congenital Heart Disease
NCT06796127Congenital Heart Disease (CHD), Artificial Intelligence (AI)
Beijing Anzhen Hospital
Observational
10,000
Beijing
2025-02-01
Recruiting
Chronic Airway Disease and Multimorbidity Cohort
NCT06798077Chronic Obstructive Pulmonary Disease (COPD), Asthma, Bronchiectasis
China-Japan Friendship Hospital
Observational
2,000
Beijing, Guangzhou, Zhengzhou, Wuhan, Changsha, Shenyang, Xi'an, Shanghai
2025-02-01
By invitation
Pharvaris Netherlands B.V.
Phase 3
170
Beijing
2025-02-01
Not yet open
xiang yang
Phase 2
26
Beijing
2025-02-01
Not yet open
Capital Medical University
Phase 3
1,000
Beijing
2025-02-01
Recruiting
Beijing Tiantan Hospital
Not applicable
30
Beijing
2025-02-01
Not yet open
A Multicentric Cohort of Autoimmune Encephalitis
NCT06760091Autoimmune Encephalitis
Xuanwu Hospital, Beijing
Observational
200
Beijing
2025-02-01
Recruiting
A Chinese Multicenter Study on Surgical Techniques and Outcomes Across the Lifespan in Congenital Heart Disease
NCT07524998Congenital Heart Disease, Complex Congenital Heart Disease, Surgery (Cardiac), Perioperative Care
China National Center for Cardiovascular Diseases
Observational
3,000
Beijing
2025-02-01
Not yet open
Beijing Tiantan Hospital
Not applicable
160
Beijing, Lianyungang
2025-02-01
Not yet open
A Cohort Study on Biomarkers to Predict the Efficacy of Biologics for Chronic Rhinosinusitis with Nasal Polyps
NCT06801353Chronic Rhinosinusitis with Nasal Polyps (CRSwNP), Biological Therapy, Biomarkers
DrugsMometasone furoate·Stapokibart
Beijing Tongren Hospital
Phase 4
90
Beijing
2025-02-01
Recruiting
Beijing Chao Yang Hospital
Not applicable
200
Beijing, Guangzhou, Zhengzhou, Changsha, Shenyang, Shanghai, Taiyuan, Hangzhou
2025-02-01
Recruiting
Peking University First Hospital
Not applicable
572
Beijing
2025-02-01
Not yet open
Peking University
Phase 2
63
Beijing
2025-02-01
Not yet open
Keymed Biosciences Co.Ltd
Phase 2
150
Beijing
2025-02
Not yet open
Tsinghua University
Not applicable
45
Beijing
2025-02
Not yet open
SMART Study in Real World
NCT06780696Hypertension, Uncontrolled Hypertension, Resistant Hypertension, Reduce Antihypertensive Drug Burden
SyMap Medical (Suzhou), Ltd.
Observational
1,000
Beijing
2025-02
Recruiting
China-Japan Friendship Hospital
Not applicable
94
Beijing
2025-02
Not yet open
Suzhou Suncadia Biopharmaceuticals Co., Ltd.
Phase 4
1,564
Beijing
2025-02
Not yet open
Adebrelimab Maintenance Therapy After Concurrent Chemoradiotherapy with Hyperfractionated Radiotherapy in Limited-Stage Small Cell Lung Cancer
NCT06784206Small Cell Lung Cancer, Limited Stage, Hyperfractionated Accelerated Radiotherapy, Simultaneous Radiotherapy and Chemotherapy
Peking University Cancer Hospital & Institute
Phase 2
30
Beijing
2025-02
Not yet open
Suzhou Suncadia Biopharmaceuticals Co., Ltd.
Phase 3
90
Beijing, Shanghai
2025-02
Recruiting
Sinocelltech Ltd.
Phase 1/2
168
Beijing, Changchun, Guangzhou, Hangzhou, Jiujiang, Kunming, Linfen, Mianyang
2025-02
Recruiting
Beijing Tiantan Hospital
Early Phase 1
9
Beijing
2025-01-31
Not yet open
Chinese PLA General Hospital
Observational
300
Beijing
2025-01-30
Recruiting
A Study of AZD0486 Monotherapy or in Combination With Other Anti-Cancer Agents for Mature B-Cell Malignancies
NCT06564038Chronic Lymphocytic Leukaemia, Small Lymphocytic Lymphoma, Mantle-cell Lymphoma, Large B-cell Lymphoma
DrugsSurovatamig·Acalabrutinib·Vincristine·Doxorubicin
AstraZeneca
Phase 1/2
408
Beijing, Guangzhou, Jinan, Tianjin, Zhengzhou
2025-01-30
Active, closed
Study of Anti-CEACAM5 ADC M9140 in Participants With Advanced Solid Tumors (PROCEADE PanTumor)
NCT06710132Solid Tumors, Gastric Cancer, Non-Small Cell Lung Cancer (NSCLC), Pancreatic Cancer
DrugM9140
EMD Serono Research & Development Institute, Inc.
Phase 1/2
184
Hefei, Beijing, Guangzhou, Wuhan, Harbin, Changsha, Chengdu, Hangzhou
2025-01-29
By invitation
Beijing Chest Hospital
Phase 2
12
Beijing
2025-01-28
Recruiting
Merck Sharp & Dohme LLC
Phase 3
1,046
Hefei, Beijing, Chongqing, Fuzhou, Xiamen, Guangzhou, Nanning, Guiyang
2025-01-27
Recruiting
Phase III Trial of VDJ001 In Patients With Idiopathic Multicentric Castleman Disease
NCT07872423Anti IL-6R, Castleman's Disease, Multicentric
Beijing VDJBio Co., LTD.
Phase 3
45
Beijing, Xiamen, Wuhan, Nanjing, Nanchang, Taiyuan, Chengdu, Hangzhou
2025-01-27
Recruiting
Tsinghua University
Not applicable
84
Beijing
2025-01-26
Recruiting
Diagnosis and Allergen Identification of Perioperative Anaphylaxis
NCT06793163Perioperative/Postoperative Complications, Anaphylaxis, Tryptase, Allergens
Peking University First Hospital
Observational
115
Beijing
2025-01-25
Recruiting
Beijing Tiantan Hospital
Not applicable
535
Beijing
2025-01-25
Recruiting
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Phase 2
128
Beijing
2025-01-25
Recruiting
Peking Union Medical College Hospital
Phase 2
40
Beijing
2025-01-25
Recruiting
Beijing Tsinghua Chang Gung Hospital
Not applicable
76
Beijing
2025-01-24
Recruiting
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Phase 2
49
Beijing
2025-01-24
Recruiting
Beijing Tiantan Hospital
Not applicable
108
Beijing
2025-01-24
Recruiting
Shenzhen Ionova Life Sciences Co., Ltd.
Phase 1/2
84
Beijing, Fuzhou, Foshan, Zhengzhou, Changsha, Nanjing, Nanchang, Shenyang
2025-01-23
Recruiting
BeOne Medicines
Phase 1/2
258
Beijing, Guangzhou, Suzhou
2025-01-23
Recruiting
MZL-IPI Risk-adapted Targeted Therapy in Untreated MZL
NCT06793189Marginal Zone Lymphoma(MZL)
DrugOrelabrutinib
Ruijin Hospital
Phase 2
145
Shanghai, Shenyang, Beijing
2025-01-23
Not yet open
Akeso
Phase 3
198
Wuhu, Beijing, Chongqing, Dongguan, Guangzhou, Jiangmen, Shenzhen, Zhuhai
2025-01-23
Recruiting
Pfizer
Phase 3
211
Hefei, Nanchang, Shanghai, Kunming, Beijing
2025-01-22
Recruiting
Ascentage Pharma Group Inc.
Phase 3
490
Beijing
2025-01-22
Active, closed
Institut de Recherches Internationales Servier
Phase 1/2
51
Beijing, Shanghai
2025-01-22
Recruiting
Shandong Suncadia Medicine Co., Ltd.
Phase 1
100
Beijing
2025-01-21
Active, closed
Bristol-Myers Squibb
Observational
153
Guangzhou, Handan, Dalian, Shanghai, Beijing
2025-01-20
By invitation
ARTLifeLine: Assisted Reproduction Technology (ART) Family Health and Development Trajectory Cohort (ARTLL)
NCT06786871Reproductive Techniques, Assisted, Family, Cohort Studies, Development, Infant
Peking University Third Hospital
Observational
100,000
Beijing
2025-01-20
Active, closed
Peking University Aerospace Center Hospital
Not applicable
137
Beijing
2025-01-20
Recruiting
Beijing Visionly Plus Eye Hospital
Not applicable
1,000
Beijing
2025-01-20
Recruiting
A Pilot Trial of Pressure Muscle Index-Targeted PSV Trial
NCT06769360Critical Care, Acute Hypoxic Respiratory Failure, Ventilator Lung
Capital Medical University
Not applicable
60
Beijing
2025-01-20
Active, closed
Bisirna Therapeutics (Suzhou) Co., Ltd.
Phase 1
40
Beijing
2025-01-20
Recruiting
AbbVie
Phase 2
150
Beijing, Fuzhou, Nanning, Harbin, Zhengzhou, Wuhan, Nanchang, Xi'an
2025-01-20
Recruiting
CAR2219 CAR-T Cells for the Treatment of R/R B Cell Leukemia and Lymphoma
NCT06834529Relapsed or Refractory B Cell Leukemia and Lymphoma
Affiliated Hospital to Academy of Military Medical Sciences
Phase 1/2
20
Beijing
2025-01-20
Recruiting
Efficacy and Safety of Remimazolam Besylate for Sedation in Post-Non-Cardiac Surgery Patients Requiring Mechanical Ventilation
NCT06575530Effect of Drug, Adverse Drug Event, Mechanical Ventilation Complication, Critical Illness
DrugsRemimazolam Besylate·Dexmedetomidine
Beijing Shijitan Hospital, Capital Medical University
Phase 4
306
Beijing
2025-01-20
By invitation
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Observational
300
Beijing
2025-01-19
Recruiting
Beijing GoBroad Hospital
Early Phase 1
3
Beijing
2025-01-18
Recruiting
PCCT-Defined High-Risk Plaque and Future Coronary Events: The PREDICT Study
NCT07822737Coronary Artery Disease, Plaque, Photon-Counting Computed Tomography
Beijing Chao Yang Hospital
Observational
500
Beijing
2025-01-18
Recruiting
Xuanwu Hospital, Beijing
Not applicable
20
Beijing
2025-01-18
Active, closed
Daihong Liu
Phase 1
30
Beijing
2025-01-17
Recruiting
Akeso
Phase 1/2
280
Beijing
2025-01-17
Recruiting
Sintilimab Combined With Chemotherapy as Adjuvant Treatment for Phase III GC and GEJ
NCT06761846Gastric Adenocarcinoma, Esophagogastric Junction Adenocarcinoma
DrugSintilimab
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Phase 2
70
Beijing
2025-01-17
Active, closed
Sinocare
Not applicable
160
Beijing, Chongqing, Shunde, Wuhan, Jinan, Shanghai
2025-01-17
Recruiting
Hangzhou Hanx Biopharmaceuticals, Ltd.
Phase 1/2
124
Beijing
2025-01-17
Active, closed
Efficacy, Safety, PK, PD, and ADA of Eculizumab in Chinese Adults With NMOSD
NCT06724809NMOSD, Neuromyelitis Optica Spectrum Disorders
DrugEculizumab
Alexion Pharmaceuticals, Inc.
Phase 3
21
Beijing, Dongguan, Jinan, Shanghai, Taiyuan, Wenzhou, Wuhan
2025-01-16
Active, closed
Gan & Lee Pharmaceuticals.
Phase 3
274
Beijing
2025-01-16
By invitation
Capital Medical University
Not applicable
750
Beijing
2025-01-16
Not yet open
Peking University Cancer Hospital & Institute
Phase 2
70
Beijing
2025-01-15
Active, closed
Artificial Intelligence-assisted Diagnosis
NCT06783933Congenital Heart Disease (CHD), Structural Heart Disease
China National Center for Cardiovascular Diseases
Observational
60,000
Beijing
2025-01-15
Recruiting
Beijing Anzhen Hospital
Observational
150
Beijing
2025-01-15
Not yet open
Peking University Third Hospital
Observational
300
Beijing
2025-01-15
Recruiting
A Study of XS-04 in Patients With Relapsed or Refractory Hematologic Malignancies
NCT06820268B-cell Lymphoma, Acute Myeloid Leukemia, Myelodysplastic Syndrome
Shanghai Fosun Pharmaceutical Industrial Development Co. Ltd.
Phase 1
168
Beijing, Guangdong, Hebei, Hubei
2025-01-14
Recruiting
Correlation Analysis of POD and pNCD in Elderly Spinal Surgery Patients
NCT06466083Postoperative Delirium, Postoperative Neurocognitive Disorder, Spinal Surgery
Xuanwu Hospital, Beijing
Observational
165
Beijing
2025-01-14
Active, closed
BrightGene Bio-Medical Technology Co., Ltd.
Phase 3
537
Beijing
2025-01-13
Not yet open
MxA and CRP-Guided Use of Antimicrobial Agents for AECOPD
NCT06779344Acute Exacerbation Chronic Obstructive Pulmonary Disease
Capital Medical University
Not applicable
458
Beijing
2025-01-13
Recruiting
Shanghai Auzone Biological Technology Co., Ltd.
Phase 2
150
Beijing, Changsha, Chengdu, Nanjing, Tianjin
2025-01-13
Recruiting
Cisen Pharmaceutical CO., LTD.
Phase 2
108
Beijing
2025-01-13
Recruiting
Beijing Tiantan Hospital
Phase 4
128
Beijing
2025-01-10
Recruiting
Hebei Senlang Biotechnology Inc., Ltd.
Phase 2
59
Beijing
2025-01-10
Recruiting
Peking University People's Hospital
Not applicable
81
Beijing
2025-01-10
Active, closed
Tsinghua University
Not applicable
900
Beijing, Shanghai
2025-01-10
Recruiting
BeOne Medicines
Phase 1
695
Hefei, Beijing, Chongqing, Fuzhou, Xiamen, Guangzhou, Meizhou, Nanning
2025-01-10
Recruiting
Fortvita Biologics (USA)Inc.
Phase 1
250
Hefei, Beijing, Fuzhou, Nanning, Harbin, Anyang, Luoyang, Zhengzhou
2025-01-10
Recruiting
Chengdu Brilliant Pharmaceutical Co., Ltd.
Phase 1
48
Beijing
2025-01-10
By invitation
Shaanxi Giant Biotechnology Co., Ltd
Not applicable
244
Beijing
2025-01-10
Not yet open
Capital Medical University
Early Phase 1
6
Beijing
2025-01-10
Not yet open
Beijing Anzhen Hospital
Phase 4
30
Beijing
2025-01-10
Recruiting
GeneQuantum Healthcare (Suzhou) Co., Ltd.
Phase 3
228
Bengbu, Fuyang, Hefei, Beijing, Chongqing, Fuzhou, Quanzhou, Guangzhou
2025-01-10
By invitation
Peking University People's Hospital
Observational
100
Beijing
2025-01-09
Recruiting
Peking Union Medical College Hospital
Not applicable
40
Beijing, Wenzhou
2025-01-09
Active, closed
Janssen Research & Development, LLC
Phase 3
813
Beijing, Changchun, Changsha, Chengdu, Chongqing, Dongguan, Guangzhou, Guiyang
2025-01-09
Active, closed
Study Evaluating PEG-G-CSF Injectionin Preventing Neutropenia After Chemotherapy
NCT06711523Neutropenia, Chemotherapy-Induced Febrile, Breast Neoplasm Female
Kexing Biopharm Co., Ltd.
Phase 3
250
Beijing
2025-01-09
Active, closed
TJ Biopharma Co., Ltd.
Phase 2
150
Beijing, Binzhou, Chengdu, Chongqing, Ha’erbin, Hefei, Jiangmen, Kunming
2025-01-09
Rows per page Showing 2501–3000 of 5576
Previous 4 5 6 7 8 Next
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Chinese investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 9 November 2026. https://priyalifescience.com/clinical-trials-china/city/beijing?page=6

Query this register directly
GET /api/trials?country=cn&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in China and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 19,187 studies in total at the last sync on 08 Nov 2026, 03:17 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 5,576 of those studies with a site in Beijing.

How many clinical trials are recruiting in Beijing?

3,389 of the 5,576 studies on this page are recruiting new participants as of the 08 Nov 2026, 03:17 UTC sync. A further 990 have not yet opened recruitment, 1,019 are active but closed to new participants, and 178 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and India registers.